Elevance Health Cost of Goods Sold 2010-2024 | ELV

Elevance Health annual/quarterly cost of goods sold history and growth rate from 2010 to 2024. Cost of goods sold can be defined as the difference between beginning and ending inventories for tangible products resulting in an expense that reflects production and sales costs.
  • Elevance Health cost of goods sold for the quarter ending September 30, 2024 was $38.042B, a 7.91% increase year-over-year.
  • Elevance Health cost of goods sold for the twelve months ending September 30, 2024 was $143.976B, a 3.36% increase year-over-year.
  • Elevance Health annual cost of goods sold for 2023 was $141.623B, a 9.21% increase from 2022.
  • Elevance Health annual cost of goods sold for 2022 was $129.677B, a 14.29% increase from 2021.
  • Elevance Health annual cost of goods sold for 2021 was $113.466B, a 16.98% increase from 2020.
Elevance Health Annual Cost of Goods Sold
(Millions of US $)
2023 $141,623
2022 $129,677
2021 $113,466
2020 $96,998
2019 $83,778
2018 $71,895
2017 $72,236
2016 $66,834
2015 $61,117
2014 $56,855
2013 $56,237
2012 $48,214
2011 $47,648
2010 $44,930
2009 $47,541
Elevance Health Quarterly Cost of Goods Sold
(Millions of US $)
2024-09-30 $38,042
2024-06-30 $35,392
2024-03-31 $34,371
2023-12-31 $36,171
2023-09-30 $35,254
2023-06-30 $35,931
2023-03-31 $34,267
2022-12-31 $33,841
2022-09-30 $32,858
2022-06-30 $31,864
2022-03-31 $31,114
2021-12-31 $30,534
2021-09-30 $29,543
2021-06-30 $27,377
2021-03-31 $26,012
2020-12-31 $26,610
2020-09-30 $25,143
2020-06-30 $21,772
2020-03-31 $23,473
2019-12-31 $22,532
2019-09-30 $21,498
2019-06-30 $20,466
2019-03-31 $19,282
2018-12-31 $18,936
2018-09-30 $18,185
2018-06-30 $17,728
2018-03-31 $17,046
2017-12-31 $18,672
2017-09-30 $18,104
2017-06-30 $17,917
2017-03-31 $17,543
2016-12-31 $17,568
2016-09-30 $16,923
2016-06-30 $16,805
2016-03-31 $15,539
2015-12-31 $16,316
2015-09-30 $15,469
2015-06-30 $15,205
2015-03-31 $14,127
2014-12-31 $14,858
2014-09-30 $14,211
2014-06-30 $14,121
2014-03-31 $13,665
2013-12-31 $14,581
2013-09-30 $14,075
2013-06-30 $13,833
2013-03-31 $13,749
2012-12-31 $12,291
2012-09-30 $12,051
2012-06-30 $12,100
2012-03-31 $11,772
2011-12-31 $12,435
2011-09-30 $12,063
2011-06-30 $11,922
2011-03-31 $11,228
2010-12-31 $11,357
2010-09-30 $11,206
2010-06-30 $10,986
2010-03-31 $11,382
2009-12-31 $12,068
2009-09-30 $11,666
2009-06-30 $11,971
2009-03-31 $11,837
Sector Industry Market Cap Revenue
Medical Medical Services $91.424B $171.340B
Elevance Health Inc. operates as a health benefits company. It supports consumers, families and communities across the entire care journey connecting to the care, support and resources to lead healthier lives. Elevance Health Inc., formerly known as Anthem Inc., is based in Indianapolis, Indiana.
Stock Name Country Market Cap PE Ratio
Cencora (COR) United States $47.484B 17.51
DiDi Global (DIDIY) China $23.330B 0.00
Natera (NTRA) United States $21.401B 0.00
ICON (ICLR) Ireland $16.136B 14.37
Viatris (VTRS) United States $15.576B 4.80
Avantor (AVTR) United States $13.422B 20.12
Revvity (RVTY) United States $13.376B 23.24
CochLear (CHEOY) Australia $12.844B 0.00
BioMerieux (BMXMF) France $12.666B 0.00
Solventum (SOLV) United States $11.583B 0.00
Medpace Holdings (MEDP) United States $9.789B 27.58
Doximity (DOCS) United States $9.620B 56.63
Charles River Laboratories (CRL) United States $9.516B 18.39
HealthEquity (HQY) United States $8.966B 48.66
Sonic Healthcare (SKHHY) Australia $8.758B 0.00
Bausch + Lomb (BLCO) Canada $6.885B 32.05
Life Times (LTH) United States $5.085B 33.66
Sotera Health (SHC) United States $3.855B 20.62
Organon (OGN) United States $3.757B 3.79
BrightSpring Health Services (BTSG) United States $3.247B 69.07
Surgery Partners (SGRY) United States $2.892B 32.97
PACS (PACS) United States $2.606B 0.00
Concentras Parent (CON) United States $2.581B 0.00
Ardent Health Partners (ARDT) United States $2.375B 0.00
Premier (PINC) United States $2.143B 11.15
Alignment Healthcare (ALHC) United States $2.126B 0.00
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
GeneDx Holdings (WGS) United States $1.952B 0.00
GoodRx Holdings (GDRX) United States $1.616B 42.40
Teladoc Health (TDOC) United States $1.537B 0.00
Pediatrix Medical (MD) United States $1.255B 12.28
CareDx (CDNA) United States $1.183B 0.00
Progyny (PGNY) United States $1.164B 23.57
Establishment Labs Holdings (ESTA) $1.050B 0.00
AMN Healthcare Services Inc (AMN) United States $0.954B 6.46
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
Embecta (EMBC) United States $0.778B 5.18
SBC Medicals (SBC) United States $0.677B 0.00
Agilon Health (AGL) United States $0.655B 0.00
InnovAge Holding (INNV) United States $0.647B 0.00
Auna S.A (AUNA) Luxembourg $0.536B 0.00
Sonida Senior Living (SNDA) United States $0.425B 0.00
DocGo (DCGO) United States $0.410B 15.46
Enhabit (EHAB) United States $0.366B 31.61
COMPASS Pathways (CMPS) United Kingdom $0.326B 0.00
LifeMD (LFMD) United States $0.241B 0.00
ModivCare (MODV) United States $0.223B 12.09
Sera Prognostics (SERA) United States $0.209B 0.00
Beauty Health (SKIN) United States $0.200B 0.00
Biodesix (BDSX) United States $0.180B 0.00
Nutex Health (NUTX) United States $0.156B 0.00
Ascend Wellness Holdings (AAWH) United States $0.100B 0.00
So-Young (SY) China $0.092B 22.25
MultiPlan (MPLN) United States $0.084B 0.00
Singular Genomics Systems (OMIC) United States $0.054B 0.00
OncoCyte (OCX) United States $0.043B 0.00
NeueHealth (NEUE) United States $0.041B 1.08
Co-Diagnostics (CODX) United States $0.034B 0.00
Pheton Holdings (PTHL) China $0.030B 0.00
IceCure Medical (ICCM) Israel $0.028B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.020B 0.00
Oncology Institute (TOI) United States $0.014B 0.00
SeaStar Medical Holding (ICU) United States $0.009B 0.00
XWELL (XWEL) United States $0.008B 0.00
Intelligent Bio Solutions (INBS) United States $0.006B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00